DMT-dI

• Description:

  DMT-dI (5'-O-DMT-dI) is a deoxyribonucleoside containing a hypoxanthine base. DMT-dI can be used to prepare convertible nucleoside derivatives to prepare modified oligonucleotides complementary to target genes for gene editing. DMT-dI can be used to study various conditions, disorders or diseases modified by adenosine[1].

• Product Name Alternative:

  5'-O-DMT-dI; 2'-Deoxy-5'-O-DMT-inosine

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H320, H335

• Target:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/dmt-di.html

• Purity:

  99.40

• Solubility:

  DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles:

  O[C@H]1C[C@H](N2C(N=CNC3=O)=C3N=C2)O[C@@H]1COC(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6

• Molecular Formula:

  C31H30N4O6

• Molecular Weight:

  554.59

• Precautions:

  H302, H315, H320, H335

• References & Citations:

  [1]Preparation of modified oligonucleotide complimentary to target genes for gene editing. World Intellectual Property Organization, WO2023220440 A1 2023-11-16.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Oligonucleotides

• Clinical Information:

  No Development Reported

• CAS Number:

  93778-57-5